675 related articles for article (PubMed ID: 20620241)
1. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.
Fiocco U; Sfriso P; Lunardi F; Pagnin E; Oliviero F; Scagliori E; Cozzi L; Vezzù M; Molena B; Scanu A; Panziera C; Nardacchione R; Rubaltelli L; Dayer JM; Calabrese F; Punzi L
Autoimmun Rev; 2010 Sep; 9(11):780-4. PubMed ID: 20620241
[TBL] [Abstract][Full Text] [Related]
2. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
[TBL] [Abstract][Full Text] [Related]
3. Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitis.
Molena B; Sfriso P; Oliviero F; Pagnin E; Teramo A; Lunardi F; Stramare R; Scanu A; Nardacchione R; Rubaltelli L; Calabrese F; Punzi L; Fiocco U
Clin Exp Rheumatol; 2011; 29(3):547-50. PubMed ID: 21640049
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast formation and function in pigmented villonodular synovitis.
Taylor R; Kashima TG; Knowles H; Gibbons CL; Whitwell D; Athanasou NA
J Pathol; 2011 Sep; 225(1):151-6. PubMed ID: 21706481
[TBL] [Abstract][Full Text] [Related]
5. Tenosynovial giant cell tumor: case report and review.
Lucas DR
Arch Pathol Lab Med; 2012 Aug; 136(8):901-6. PubMed ID: 22849738
[TBL] [Abstract][Full Text] [Related]
6. Tumour necrosis factor alpha blockade in treatment resistant pigmented villonodular synovitis.
Kroot EJ; Kraan MC; Smeets TJ; Maas M; Tak PP; Wouters JM
Ann Rheum Dis; 2005 Mar; 64(3):497-9. PubMed ID: 15297283
[TBL] [Abstract][Full Text] [Related]
7. [Synovial giant cell tumor or nodular circumscribed form of pigmented villonodular synovitis?].
Bruns J; Eggers-Ströder G; von Torklus D
Z Orthop Ihre Grenzgeb; 1993; 131(1):22-7. PubMed ID: 8480435
[TBL] [Abstract][Full Text] [Related]
8. Pigmented villonodular synovitis therapy with MSCF-1 inhibitors.
Temple HT
Curr Opin Oncol; 2012 Jul; 24(4):404-8. PubMed ID: 22572726
[TBL] [Abstract][Full Text] [Related]
9. Pigmented villonodular synovitis: a disease in evolution.
Bouali H; Deppert EJ; Leventhal LJ; Reeves B; Pope T
J Rheumatol; 2004 Aug; 31(8):1659-62. PubMed ID: 15290750
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
Cassier PA; Gelderblom H; Stacchiotti S; Thomas D; Maki RG; Kroep JR; van der Graaf WT; Italiano A; Seddon B; Dômont J; Bompas E; Wagner AJ; Blay JY
Cancer; 2012 Mar; 118(6):1649-55. PubMed ID: 21823110
[TBL] [Abstract][Full Text] [Related]
11. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
[TBL] [Abstract][Full Text] [Related]
12. Cell characterization of mononuclear and giant cells constituting pigmented villonodular synovitis.
Yoshida W; Uzuki M; Kurose A; Yoshida M; Nishida J; Shimamura T; Sawai T
Hum Pathol; 2003 Jan; 34(1):65-73. PubMed ID: 12605368
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms of synovial hyperplasia in rheumatoid arthritis and pigmented villonodular synovitis: the role of telomerase activity in synovial proliferation.
Yudoh K; Matsuno H; Nezuka T; Kimura T
Arthritis Rheum; 1999 Apr; 42(4):669-77. PubMed ID: 10211880
[TBL] [Abstract][Full Text] [Related]
14. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
[TBL] [Abstract][Full Text] [Related]
15. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
West RB; Rubin BP; Miller MA; Subramanian S; Kaygusuz G; Montgomery K; Zhu S; Marinelli RJ; De Luca A; Downs-Kelly E; Goldblum JR; Corless CL; Brown PO; Gilks CB; Nielsen TO; Huntsman D; van de Rijn M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):690-5. PubMed ID: 16407111
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis and pigmented villonodular synovitis: comparative analysis of cell polyploidy, cell cycle phases and expression of macrophage and fibroblast markers in proliferating synovial cells.
Berger I; Weckauf H; Helmchen B; Ehemann V; Penzel R; Fink B; Bernd L; Autschbach F
Histopathology; 2005 May; 46(5):490-7. PubMed ID: 15842630
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic difficulties in pigmented villonodular synovitis. Presentation of cases.
Panasiuk M; Iwański A
Ortop Traumatol Rehabil; 2008; 10(6):613-9. PubMed ID: 19153550
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
[TBL] [Abstract][Full Text] [Related]
19. [Pigmented villonodular synovitis].
Aalberg JR; Hansen P
Ugeskr Laeger; 1989 Sep; 151(38):2413-6. PubMed ID: 2800012
[TBL] [Abstract][Full Text] [Related]
20. [Iron deposits, cell populations and proliferative activity in pigmented villonodular synovitis of the knee joint].
Aigner T; Oehler S; Niedobitek HG; Fassbender G; Kirchner T
Verh Dtsch Ges Pathol; 1998; 82():327-31. PubMed ID: 10095454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
